Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Expanded_access × Solid Tumor × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 254 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 24 Carcinoma, Non-Small-Cell Lung 23 Recurrence 22 Neoplasms 22 Melanoma 18 Leukemia, Myeloid, Acute 14 Breast Neoplasms 13 Prostatic Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Pancreatic Neoplasms 9 Sarcoma 8 Ovarian Neoplasms 8 Lymphoma, Large B-Cell, Diffuse 8 Lung Neoplasms 8 Glioblastoma 8 Colorectal Neoplasms 8 Lymphoma 7 Small Cell Lung Carcinoma 6 Lymphoma, Non-Hodgkin 6 Cholangiocarcinoma 6 Carcinoma, Renal Cell 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Glioma 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, Mantle-Cell 4 Gastrointestinal Stromal Tumors 4 Carcinoma, Transitional Cell 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04644107 2020-11-25

Expanded Access for Marizomib

Celgene

No longer available

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡